Catalyst Wire Dossier Catalyst Wire Dossier

Albutein 5%

· Grifols Therapeutics LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Albutein 5%, covering 2021-05-05 to 2021-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis [Phase 2]

See pricing